Apple update brings interoperability to the Health app

Apple has announced a new update for the Health app with the iOS 11.3 beta, which allows users to access medical records from various healthcare organizations through their iPhone.

The updated Health Records section within the Health app on iPhones will now contain patients’ medical records held from different healthcare organizations. Johns Hopkins Medicine, Cedars-Sinai and Penn Medicine are currently some of the organizations participating in the update of the app.

“Our goal is to help consumers live a better day. We’ve worked closely with the health community to create an experience everyone has wanted for years — to view medical records easily and securely right on your iPhone,” said Jeff Williams, Apple’s COO. “By empowering customers to see their overall health, we hope to help consumers better understand their health and help them lead healthier lives.”

This type of interoperability between online health records is meant to engage patients in their care by offering an easy view of their medical state from a single device. Currently, users are able to access information regarding allergies, conditions, immunizations, lab results, medications, procedures and vitals. Data is encrypted and protected by each iPhone’s password and users are notified when information become updated.

“Putting the patient at the center of their care by enabling them to direct and control their own health records has been a focus for us at Cedars-Sinai for some time. We are thrilled to see Apple taking the lead in this space by enabling access for consumers to their medical information on their iPhones. Apple is uniquely positioned to help scale adoption because they have both a secure and trusted platform and have adopted the latest industry open standards at a time when the industry is well positioned to respond,” said Darren Dworkin, chief information officer at Cedars-Sinai.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.